Early research (Phase 1)UnknownNCT03634982What this trial is testingDose Escalation of RMC-4630 Monotherapy in Relapsed/Refractory Solid TumorsWho this might be right forSolid Tumors Revolution Medicines, Inc. 133
Testing effectiveness (Phase 2)Study completedNCT04173507What this trial is testingCombination Treatment (Talazoparib Plus Avelumab) for Stage IV or Recurrent Non-Squamous Non-Small Cell Lung Cancer With STK11 Gene Mutation (A LUNG-MAP Treatment Trial)Who this might be right forAdvanced Lung Non-Squamous Non-Small Cell CarcinomaRecurrent Lung Non-Squamous Non-Small Cell CarcinomaStage IV Lung Cancer AJCC v8+2 more SWOG Cancer Research Network 47
Large-scale testing (Phase 3)Study completedNCT01836575What this trial is testingAlimta® Versus Its Combination With Carboplatin in Advanced Non-small-cell Lung Cancer in Patients Performance Status 2Who this might be right forNon Small Cell Lung Carcinoma Instituto Nacional de Cancer, Brazil 228
Testing effectiveness (Phase 2)Active Not RecruitingNCT05094336What this trial is testingAnvumetostat in Participants With Advanced MTAP-null Solid Tumors (MTAPESTRY 101)Who this might be right forAdvanced MTAP-null Solid Tumors Amgen 329
Early research (Phase 1)Study completedNCT03780010What this trial is testingStudy of TRC105 + Paclitaxel/Carboplatin and Bevacizumab in Patients With NSCLCWho this might be right forNon Small Cell Lung Cancer Tracon Pharmaceuticals Inc. 15
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07134413What this trial is testingQL1706/Bevacizumab ± Chemotherapy in Post-ICI Non-Squamous NSCLCWho this might be right forNSCLC Guangdong Association of Clinical Trials 77
Testing effectiveness (Phase 2)Study completedNCT03779191What this trial is testingAlectinib in Combination With Bevacizumab in ALK Positive NSCLCWho this might be right forALK Gene Rearrangement PositiveNon-Squamous Non-Small Cell Neoplasm of Lung Instituto Nacional de Cancerologia de Mexico 41
Early research (Phase 1)Looking for participantsNCT07164313What this trial is testingZW251 in Participants With Advanced Solid TumorsWho this might be right forHepatocellular CarcinomaSquamous Cell Non-Small Cell Lung CancerGerm Cell Tumor Zymeworks BC Inc. 100
Post-approval studies (Phase 4)Not Yet RecruitingNCT07633613What this trial is testingPharmacokinetic Study of Pembrolizumab and Its Impact on Immunity and the Tumor Microenvironment, Which May Explain the Efficacy of Post-immunotherapy Chemotherapy.Who this might be right forNon-Small Cell Lung Carcinoma (NSCLC)Metastatic Head and Neck Squamous Cell Carcinoma Centre Antoine Lacassagne 110
Early research (Phase 1)Ended earlyNCT02029690What this trial is testingPh 1 Study in Subjects With Tumors Requiring Arginine to Assess ADI-PEG 20 With Pemetrexed and CisplatinWho this might be right forPleural Mesothelioma Malignant AdvancedPeritoneal Mesothelioma Malignant AdvancedNon-squamous Non-small Cell Lung Carcinoma+4 more Polaris Group 85
Testing effectiveness (Phase 2)Looking for participantsNCT06772623What this trial is testingStudy to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic AlterationsWho this might be right forNon Small Cell Lung Carcinoma AbbVie 252
Testing effectiveness (Phase 2)Study completedNCT02340208What this trial is testingA Phase I/II Open-Label, Non-Randomized Dose Escalation Study of Immunoconjugate L-DOS47Who this might be right forNon-Small Cell Lung Cancer Helix BioPharma Corporation 76
Early research (Phase 1)UnknownNCT04432857What this trial is testingAN0025 and Pembrolizumab Combination in Advanced Solid TumorsWho this might be right forTriple-negative Breast CancerNSCLC, Squamous or Non-SquamousUrothelial Carcinoma of the Bladder+2 more Adlai Nortye Biopharma Co., Ltd. 63
Testing effectiveness (Phase 2)Study completedNCT00729612What this trial is testingPaclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung CancerWho this might be right forLung Cancer Greg Otterson 63
Testing effectiveness (Phase 2)Looking for participantsNCT05692635What this trial is testingReducing the Incidence of Symptomatic Brain Metastases With MRI SurveillanceWho this might be right forBrain MetastasesNonsmall Cell Lung Cancer Stage III Wake Forest University Health Sciences 60
Large-scale testing (Phase 3)UnknownNCT00955695What this trial is testingRadiation Therapy to the Brain or Observation in Preventing Brain Metastases in Patients With Advanced Non-Small Cell Lung CancerWho this might be right forLung Cancer National Cancer Center, Korea 242
Not applicableUnknownNCT02397239What this trial is testingComparison of Cost-effectiveness of Continuation Maintenance Therapy With Six Cycles of Pemetrexed Versus Pemetrexed Until Disease Progression for Metastatic Non-squamous Non-small-cell Lung CancerWho this might be right forNon-Small Cell Lung Cancer National Cheng-Kung University Hospital 72
Large-scale testing (Phase 3)Study completedNCT02810457What this trial is testingEvaluation of FKB238 and Avastin in Patients With Advanced/Recurrent Non-squamous Non-small Cell Lung CancerWho this might be right forCarcinoma, Non-Small-Cell Lung Centus Biotherapeutics Limited 731
Post-approval studies (Phase 4)UnknownNCT03799601What this trial is testingDocetaxel Combined With Carboplatin Plus Anlotinib as First Line Treatment in NSCLCWho this might be right forNSCLC Tongji Hospital 45
Testing effectiveness (Phase 2)Study completedNCT00800202What this trial is testingAvastin (Bevacizumab) in Patients With Non-Squamous Non-Small Cell Lung Cancer With Asymptomatic Untreated Brain MetastasisWho this might be right forNon-Small Cell Lung Cancer Hoffmann-La Roche 91